Vivos (RDGL) Total Current Liabilities (2010 - 2025)
Vivos (RDGL) reported Total Current Liabilities of $117892.0 for Q4 2025, up 36.75% on a YoY basis from $86209.0 in Q4 2024, and up 4.61% sequentially from $112693.0 in Q3 2025.
Vivos (RDGL) Total Current Liabilities (2010 - 2025) Analysis & Trends
Vivos (RDGL) has 16 years of Total Current Liabilities data on file, last reported at $117892.0 in Q4 2025.
- For the quarter ending Q4 2025, Total Current Liabilities rose 36.75% year-over-year to $117892.0; the trailing twelve-month figure through Dec 2025 stood at $117892.0 (up 36.75% YoY), and the FY2025 full-year result was $117892.0, up 36.75% from the prior year.
- Total Current Liabilities climbed to $117892.0 in Q4 2025, from $112693.0 in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $687297.0 in Q1 2021 to a low of $48820.0 in Q3 2024.
- A 5-year average of $197851.8 and a median of $114094.0 in 2023 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities plunged 87.56% in 2022 and surged 199.91% in 2023, its largest moves.
- Tracing RDGL's Total Current Liabilities over 5 years: stood at $166915.0 in 2021, then plunged by 51.06% to $81692.0 in 2022, then surged by 199.91% to $245004.0 in 2023, then tumbled by 64.81% to $86209.0 in 2024, then surged by 36.75% to $117892.0 in 2025.
- Business Quant data shows RDGL's Total Current Liabilities at $117892.0 in Q4 2025, $112693.0 in Q3 2025, and $96458.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 2.22 Bn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 8.53 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 1.60 Bn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 8.70 Bn |
| 10 | Vivos | 27.16 Mn | 25.60 Mn | -3,105.00 | 117,892.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 117,892.00 |
| Sep 30, 2025 | 112,693.00 |
| Jun 30, 2025 | 96,458.00 |
| Mar 31, 2025 | 115,378.00 |
| Dec 31, 2024 | 86,209.00 |
| Sep 30, 2024 | 48,820.00 |
| Jun 30, 2024 | 166,560.00 |
| Mar 31, 2024 | 74,766.00 |
| Dec 31, 2023 | 245,004.00 |
| Sep 30, 2023 | 107,369.00 |
| Jun 30, 2023 | 112,810.00 |
| Mar 31, 2023 | 48,989.00 |
| Dec 31, 2022 | 81,692.00 |
| Sep 30, 2022 | 160,953.00 |
| Jun 30, 2022 | 215,093.00 |
| Mar 31, 2022 | 85,515.00 |
| Dec 31, 2021 | 166,915.00 |
| Sep 30, 2021 | 619,392.00 |
| Jun 30, 2021 | 607,231.00 |
| Mar 31, 2021 | 687,297.00 |